Periodontal infections cause changes in traditional and novel cardiovascular risk factors: Results from a randomized controlled clinical trial - 17/08/11
Résumé |
Background |
Chronic infections, such as periodontitis, are associated with increased risk of systemic diseases driven by a persistent low-grade systemic inflammation and metabolic changes. Severity of periodontitis has also been associated with increased systolic blood pressure (BP). However, the issue remains poorly investigated. We aimed to estimate the effect of periodontal therapy on traditional and novel cardiovascular risk factors in systemically healthy individuals who have periodontitis.
Methods |
We enrolled 40 otherwise healthy patients with severe chronic generalized periodontitis in a 6-month pilot intervention trial. Individuals were randomized either to a standard course of periodontal therapy (subgingival scaling and root planing) or an intensive one (including the adjunctive use of a locally delivered antimicrobial, IPT).
Results |
Compared to control, IPT produced significant reductions in a cluster of inflammatory markers at 1 (P = .0406) and 2 (P = .0060) months together with an improvement in lipid markers at 2 (P = .0320) and 6 (P = .0432) months after therapy. Intensive periodontal therapy produced greater reductions in IL-6 at 1 (0.4 ± 0.2 ng/L difference, 95% CI 0.03-0.9, P = .0284) and 2 months (0.3 ± 0.2 ng/L difference, 95% CI 0.1-0.8, P = .0284), together with decreases in C-reactive protein (0.4 ± 0.2 mg/L difference, 95% CI 0.01-0.8, P = .0438) and total cholesterol (0.3 ± 0.1 mmol/L difference, 95% CI 0.04-0.6, P = .0254). Moreover, a 7 ± 3-mm Hg decrease in systolic BP was observed at 2 months in the IPT group (95% CI 1-12, P = .0211), and this difference was greater in current smokers (14 ± 5 mm Hg 95% CI 3-25, P = 0.0124). Intensive periodontal therapy subjects exhibited a 1.53% ± 1.20% (95% CI 1.05-2.24, P = .0290) and 2.00% ± 1.42% (95% CI 0.98-4.09, P = .0568) decreases in cardiovascular risk scores (Framingham) at 2 and 6 months, respectively, when compared to those in the standard group.
Conclusions |
Our findings suggest that intensive periodontal treatment reduces systemic inflammatory markers and systolic BP, and improves lipid profiles with subsequent changes in cardiovascular risk when compared to standard therapy.
Le texte complet de cet article est disponible en PDF.Plan
| This study was supported by a donation from Orapharma and by the Periodontal Research Fund of the Eastman Dental Institute. The sponsors of the study had a role in study design, but not in data collection, data analysis, data interpretation, or in the writing of the report. F.D. and L.N. are supported by a fellowship from the Italian Society of Periodontology and the European Union. |
Vol 151 - N° 5
P. 977-984 - mai 2006 Retour au numéro
Article précédent
- Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers
- Juhana Karha, Vivek Rajagopal, Kandice Kottke-Marchant, Deepak L. Bhatt
- Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial
- John J.V. McMurray, James B. Young, Mark E. Dunlap, Christopher B. Granger, James Hainer, Eric L. Michelson, Steven Earle, Bertil Olofsson, Jan Östergren, Salim Yusuf, Karl Swedberg, Marc A. Pfeffer, on behalf of the CHARM Investigators
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?